Analysts Have Conflicting Sentiments on These Healthcare Companies: Allogene Therapeutics (ALLO), Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)
at www.tipranks.com (Thu, 16-Apr 5:31 AM)
BioMarin’s $850 Million Note Offering and $2 Billion Term Loan Highlight Strategic Financing for Amicus Deal
Market Chameleon (Mon, 26-Jan 8:15 AM)
